InvestSMART

AVITA Medical, Inc. (ASX: AVH) - Announcements

Current share price for AVH : $1.395 0.045 (3.33%)+

ASX company news and announcements for AVITA Medical, Inc. (AVH) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All AVITA Medical, Inc. (AVH) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than AVITA Medical, Inc. (AVH), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for AVITA Medical, Inc. (AVH)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$120 Notification of cessation of securities - AVH 3 Jul 2026 10:14AM $1.435 $1.395 fallen by 2.79%
$120 AVITA Highlights first UK Clinical Experience with RECELL GO 19 Jun 2026 8:17AM $1.125 $1.395 risen by 24%
$120 Financial Report on Form 8-K Dated 5 June 2026 11 Jun 2026 10:26AM $1.145 $1.395 risen by 21.83%
$120 Change of Director's Interest Notice -SC JCC RM JSR MT CV JW 11 Jun 2026 10:24AM $1.145 $1.395 risen by 21.83%
$120 Notification regarding unquoted securities - AVH 11 Jun 2026 10:23AM $1.145 $1.395 risen by 21.83%
$120 Notification regarding unquoted securities - AVH 11 Jun 2026 10:04AM $1.135 $1.395 risen by 22.91%
$120 Statement of CDIs on issue - AVH 4 Jun 2026 10:28AM $1.155 $1.395 risen by 20.78%
$120 2026 ASM Board Chair Script 4 Jun 2026 9:48AM $1.130 $1.395 risen by 23.45%
$120 Change of Director's Interest Notice - JW 4 Jun 2026 9:47AM $1.130 $1.395 risen by 23.45%
$120 Results of 2026 Annual Meeting of Stockholders 4 Jun 2026 9:45AM $1.130 $1.395 risen by 23.45%
$120 Change of Director's Interest Notice 3 Jun 2026 9:05AM $1.160 $1.395 risen by 20.26%
$120 Notification regarding unquoted securities - AVH 2 Jun 2026 12:55PM $1.175 $1.395 risen by 18.72%
$120 Notification of cessation of securities - AVH 2 Jun 2026 11:25AM $1.180 $1.395 risen by 18.22%
$120 AVITA AU Q1 Investor Briefing Presentation 18 May 2026 8:26AM $1.180 $1.395 risen by 18.22%
$120 AVITA Medical to Host Investor Webinar Briefing 18 May 2026 8:25AM $1.180 $1.395 risen by 18.22%
$120 Financial Results for Quarter Ending 31 March 2026 15 May 2026 8:23AM $1.200 $1.395 risen by 16.25%
$120 AVITA Medical Q1 2026 Earnings Presentation 15 May 2026 8:23AM $1.200 $1.395 risen by 16.25%
$120 AVITA Medical Reports First Quarter 2026 Financial Results 15 May 2026 8:23AM $1.200 $1.395 risen by 16.25%
$120 Statement of CDIs on issue - AVH 7 May 2026 9:20AM $1.180 $1.395 risen by 18.22%
$120 Notification of cessation of securities - AVH 5 May 2026 11:42AM $1.188 $1.395 risen by 17.47%
$120 Company Administration - Other 4 May 2026 8:12AM $1.210 $1.395 risen by 15.29%
$120 AVITA Medical Names Cary Vance as Chief Executive Officer 1 May 2026 8:17AM $1.215 $1.395 risen by 14.81%
$120 AVITA Secures Australia & NZ Clearance for RECELL GO 30 Apr 2026 8:11AM $1.210 $1.395 risen by 15.29%
$120 AVITA to Announce First Quarter 2026 Financial Results 24 Apr 2026 8:14AM $1.270 $1.395 risen by 9.84%
$120 Notice of Annual General Meeting/Proxy Form 23 Apr 2026 8:17AM $1.315 $1.395 risen by 6.08%

1 - 25 of 1347 results

Page 1 of 54

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.